← Back to Screener
GLOBUS MEDICAL INC (GMED)
Price$80.00
Value ScoreB
Growth ScoreA
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-20.05%
Price vs S&P 500 (4W)2.64%
VGM Score70.47
Market Capitalization$10.85B
P/E Ratio (Annual)20.18x
All Metrics
P/CF (Annual)14.40x
Book Value / Share (Quarterly)$34.88
P/TBV (Annual)3.07x
Revenue Growth (3Y)42.17%
Cash Flow / Share (Quarterly)$4.43
Price vs S&P 500 (YTD)-16.53%
Gross Margin (TTM)67.86%
Net Profit Margin (TTM)18.92%
EPS (TTM)$4.29
10-Day Avg Trading Volume1.77M
EPS Excl Extra (TTM)$4.29
Revenue Growth (5Y)30.08%
EPS (Annual)$3.92
ROI (Annual)11.76%
Gross Margin (Annual)67.41%
Net Profit Margin (5Y Avg)12.88%
Cash / Share (Quarterly)$4.64
P/E Basic Excl Extra (TTM)18.50x
Revenue Growth QoQ (YoY)27.04%
EPS Growth (5Y)31.11%
P/E Normalized (Annual)20.18x
ROA (Last FY)10.14%
Revenue Growth TTM (YoY)23.49%
EBITD / Share (TTM)$5.64
ROE (5Y Avg)7.23%
Operating Margin (TTM)21.03%
Cash Flow / Share (Annual)$4.29
P/B Ratio2.29x
P/B Ratio (Quarterly)2.47x
Net Income / Employee (Annual)$89,600
EV / Revenue (TTM)3.32x
Net Interest Coverage (TTM)3.54x
ROA (TTM)11.28%
EPS Growth QoQ (YoY)66.60%
EV / EBITDA (TTM)13.35x
EPS Incl Extra (Annual)$3.92
Current Ratio (Annual)4.26x
Quick Ratio (Quarterly)2.83x
3-Month Avg Trading Volume1.34M
52-Week Price Return34.34%
EV / Free Cash Flow (Annual)17.78x
P/E Incl Extra (TTM)18.50x
Revenue / Employee (TTM)$516,800
Tangible BV / Share (Quarterly)$29.57
P/S Ratio (Annual)3.69x
Asset Turnover (Annual)0.55x
52-Week High$101.40
Operating Margin (5Y Avg)15.13%
EPS Excl Extra (Annual)$3.92
CapEx CAGR (5Y)22.32%
Tangible BV CAGR (5Y)21.95%
26-Week Price Return-12.13%
Quick Ratio (Annual)2.61x
13-Week Price Return-10.40%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.56x
Enterprise Value$10.29B
Revenue / Share Growth (5Y)22.38%
Asset Turnover (TTM)0.60x
Book Value / Share Growth (5Y)17.52%
Revenue / Employee (Annual)$489,800
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)20.59%
Cash / Share (Annual)$4.13
3-Month Return Std Dev34.62%
Gross Margin (5Y Avg)68.12%
Net Income / Employee (TTM)$97,800
EBITDA CAGR (5Y)41.05%
EBITDA Interim CAGR (5Y)25.01%
ROE (Last FY)11.76%
Net Interest Coverage (Annual)45.06x
EPS Basic Excl Extra (Annual)$3.92
P/FCF (TTM)18.07x
Receivables Turnover (TTM)5.08x
EV / Free Cash Flow (TTM)17.14x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$4.29
Receivables Turnover (Annual)4.75x
ROI (TTM)13.04%
P/S Ratio (TTM)3.50x
Pretax Margin (5Y Avg)15.70%
Revenue / Share (Annual)$21.44
Tangible BV / Share (Annual)$28.35
Forward P/E16.86x
Free OCF CAGR (5Y)33.79%
Price vs S&P 500 (52W)9.98%
P/E Ratio (TTM)18.50x
EPS Growth TTM (YoY)221.15%
Year-to-Date Return-8.37%
5-Day Price Return0.28%
EPS Normalized (Annual)$3.92
ROA (5Y Avg)6.26%
Net Profit Margin (Annual)18.30%
Month-to-Date Return-2.30%
Cash Flow / Share (TTM)$2.36
EBITD / Share (Annual)$5.22
EPS Growth (3Y)28.40%
Operating Margin (Annual)20.33%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)13.94x
ROI (5Y Avg)7.13%
P/E Excl Extra (TTM)18.50x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$4.29
P/TBV (Quarterly)2.91x
P/B Ratio (Annual)2.57x
Inventory Turnover (TTM)1.39x
Pretax Margin (TTM)21.24%
Book Value / Share (Annual)$33.86
Price vs S&P 500 (13W)-18.66%
Net Margin Growth (5Y)7.13%
Beta0.95x
P/FCF (Annual)18.74x
Revenue / Share (TTM)$22.44
ROE (TTM)13.04%
52-Week Low$51.79
vGradeB
gGradeA
mGradeC
vgmGradeB
Show chart for
Earnings Surprise History
Q1 261.12est. 0.94
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.91
3.91
3.91
3.90
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GMEDGLOBUS MEDICAL INC | B | A | C | $80.00 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Globus Medical Inc develops and manufactures medical devices for surgical procedures, with a primary focus on musculoskeletal solutions for spinal and orthopedic surgery. The company serves hospitals, physicians, and surgical centers through two business segments: musculoskeletal surgical devices and enabling surgical technologies. The majority of revenue comes from musculoskeletal products, with over half generated in the United States and the remainder from international operations.